SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. )1
AtheroGenics, Inc.
-----------------------------------------------------------------
(Name of Issuer)
Common Stock
-----------------------------------------------------------------
(Title of Class of Securities)
047439 10 4
-----------------------------------------------------------------
(CUSIP Number)
December 31, 2001
-----------------------------------------------------------------
Date of Event Which Requires Filing of this Statement
Check the appropriate box to designate the rule pursuant to which this Schedule
is Filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
----------------------------
1The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page. The information required on
the remainder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act.
CUSIP No. 047439 10 4 Page 2 of 6 Pages
------------------------------------------------------------------------
1) Name of Reporting Person Domain Partners
I.R.S. Identification III, L.P.
No. of Above Person
(Entities Only)
------------------------------------------------------------------------
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
------------------------------------------------------------------------
3) SEC Use Only
------------------------------------------------------------------------
4) Citizenship or Place Delaware
of Organization
------------------------------------------------------------------------
Number of 5) Sole Voting 118,136 shares
Shares Beneficially Power of Common Stock
Owned by Each (including shares
Reporting Person issuable upon
With exercise of
warrants)
--------------------------------------------------
6) Shared Voting
Power -0-
--------------------------------------------------
7) Sole Disposi- 118,136 shares
tive Power of Common Stock
(including shares
issuable upon
exercise of
warrants)
--------------------------------------------------
8) Shared Dis-
positive Power -0-
--------------------------------------------------
9) Aggregate Amount Beneficially 118,136 shares
Owned by Each Reporting person of Common Stock (including
shares issuable upon
exercise of warrants)
------------------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
------------------------------------------------------------------------
11) Percent of Class
Represented by 0.4%
Amount in Row (9)
------------------------------------------------------------------------
12) Type of Reporting
Person PN
CUSIP No. 047439 10 4 Page 3 of 6 Pages
------------------------------------------------------------------------
1) Name of Reporting Person DP III Associates, L.P.
I.R.S. Identification
No. of Above Person
(Entities Only)
------------------------------------------------------------------------
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
------------------------------------------------------------------------
3) SEC Use Only
------------------------------------------------------------------------
4) Citizenship or Place Delaware
of Organization
------------------------------------------------------------------------
Number of 5) Sole Voting 4,088 shares
Shares Beneficially Power of Common Stock
Owned by Each (including shares
Reporting Person issuable upon
With exercise of
warrants)
--------------------------------------------------
6) Shared Voting
Power -0-
--------------------------------------------------
7) Sole Disposi- 4,088 shares
tive Power of Common Stock
(including shares
issuable upon
exercise of
warrants)
--------------------------------------------------
8) Shared Dis-
positive Power -0-
--------------------------------------------------
9) Aggregate Amount Beneficially 4,088 shares
Owned by Each Reporting person of Common Stock (including
shares issuable upon
exercise of warrants)
------------------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
------------------------------------------------------------------------
11) Percent of Class
Represented by less than 0.1%
Amount in Row (9)
------------------------------------------------------------------------
12) Type of Reporting
Person PN
CUSIP No. 047439 10 4 Page 4 of 6 Pages
Amendment No. 1 to Schedule 13G (Final Amendment)
-------------------------------------------------
Reference is hereby made to the statement on Schedule 13G originally
filed with the Securities and Exchange Commission on February 13, 2001 (the
"Schedule 13G"). Terms used in the Schedule 13G are used herein as so defined.
The following Items of the Schedule 13G are hereby amended and
restated as follows:
Item 4 - Ownership.
(a) Amount Beneficially Owned:
Domain III: 118,136 shares of Common Stock (including shares
issuable upon exercise of warrants)
DP III A: 4,088 shares of Common Stock (including shares
issuable upon exercise of warrants)
(b) Percent of Class:
Domain III: 0.4%
DP III A: less than 0.1%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
Domain III: 118,136 shares of Common Stock (including shares
issuable upon exercise of warrants)
DP III A: 4,088 shares of Common Stock (including shares
issuable upon exercise of warrants)
(ii) shared power to vote or to direct the vote: -0-
(iii) sole power to dispose or to direct the disposition of:
Domain III: 118,136 shares of Common Stock (including shares
issuable upon exercise of warrants)
DP III A: 4,088 shares of Common Stock (including shares
issuable upon exercise of warrants)
(iv) shared power to dispose or to direct the disposition
of: -0-
CUSIP No. 047439 10 4 Page 5 of 6 Pages
Item 5 - Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the
date hereof the Reporting Persons have ceased to be the beneficial owners of
more than five percent of the Common Stock, check the following [X].
CUSIP No. 047439 10 4 Page 6 of 6 Pages
Signature:
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
DOMAIN PARTNERS III, L.P.
By: One Palmer Square Associates III,
L.P., General Partner
By /s/ Kathleen K. Schoemaker
--------------------------------
General Partner
DP III ASSOCIATES, L.P.
By: One Palmer Square Associates III,
L.P., General Partner
By /s/ Kathleen K. Schoemaker
--------------------------------
General Partner
Date: January 29, 2002